Moderna Financial Statements (MRNA)
|
|
|
|
Report date
|
|
|
26.02.2021 |
25.02.2022 |
31.12.2022 |
24.02.2023 |
23.02.2024 |
|
07.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
274.5 |
17 736 |
19 263 |
19 263 |
6 848 |
|
5 083 |
|
Operating Income, bln rub |
|
|
-763.1 |
13 296 |
9 420 |
9 420 |
-4 239 |
|
-2 693 |
|
EBITDA, bln rub |
? |
|
-732.0 |
13 528 |
9 923 |
9 768 |
-3 283 |
|
-2 217 |
|
Net profit, bln rub |
? |
|
-747.1 |
12 202 |
8 362 |
8 362 |
-4 714 |
|
-2 224 |
|
|
OCF, bln rub |
? |
|
2 027 |
13 620 |
4 981 |
4 981 |
-3 118 |
|
-3 207 |
|
CAPEX, bln rub |
? |
|
67.4 |
284.0 |
400.0 |
400.0 |
707.0 |
|
749.0 |
|
FCF, bln rub |
? |
|
1 960 |
13 336 |
4 581 |
4 581 |
-3 825 |
|
-3 956 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 030 |
1 823 |
4 427 |
4 427 |
6 394 |
|
6 038 |
|
Cost of production, bln rub |
|
|
7.93 |
2 617 |
5 416 |
5 416 |
4 693 |
|
1 731 |
|
R&D, bln rub |
|
|
1 370 |
1 991 |
3 295 |
3 295 |
4 845 |
|
4 750 |
|
Interest expenses, bln rub |
|
|
9.89 |
18.0 |
0.000 |
29.0 |
38.0 |
|
24.0 |
|
|
Assets, bln rub |
|
|
7 337 |
24 669 |
25 858 |
25 858 |
18 426 |
|
15 803 |
|
Net Assets, bln rub |
? |
|
2 561 |
14 145 |
19 123 |
19 123 |
13 854 |
|
11 927 |
|
Debt, bln rub |
|
|
0.000 |
0.000 |
1 004 |
0.000 |
1 243 |
|
1 304 |
|
Cash, bln rub |
|
|
4 608 |
10 727 |
9 902 |
9 902 |
8 604 |
|
1 644 |
|
Net debt, bln rub |
|
|
-4 608 |
-10 727 |
-8 898 |
-9 902 |
-7 361 |
|
-340.0 |
|
|
Ordinary share price, rub |
|
|
104.5 |
254.0 |
179.6 |
179.6 |
99.5 |
|
71.1 |
|
Number of ordinary shares, mln |
|
|
381.3 |
403.0 |
394.0 |
394.0 |
382.0 |
|
385.0 |
|
|
Market cap, bln rub |
|
|
39 838 |
102 354 |
70 770 |
70 770 |
37 990 |
|
27 354 |
|
EV, bln rub |
? |
|
35 230 |
91 627 |
61 872 |
60 868 |
30 629 |
|
27 014 |
|
Book value, bln rub |
|
|
2 561 |
14 145 |
19 123 |
19 123 |
13 758 |
|
11 834 |
|
|
EPS, rub |
? |
|
-1.96 |
30.3 |
21.2 |
21.2 |
-12.3 |
|
-5.78 |
|
FCF/share, rub |
|
|
5.14 |
33.1 |
11.6 |
11.6 |
-10.0 |
|
-10.3 |
|
BV/share, rub |
|
|
6.72 |
35.1 |
48.5 |
48.5 |
36.0 |
|
30.7 |
|
|
EBITDA margin, % |
? |
|
-266.7% |
76.3% |
51.5% |
50.7% |
-47.9% |
|
-43.6% |
|
Net margin, % |
? |
|
-272.2% |
68.8% |
43.4% |
43.4% |
-68.8% |
|
-43.8% |
|
FCF yield, % |
? |
|
4.92% |
13.0% |
6.47% |
6.47% |
-10.1% |
|
-14.5% |
|
ROE, % |
? |
|
-29.2% |
86.3% |
43.7% |
43.7% |
-34.0% |
|
-18.6% |
|
ROA, % |
? |
|
-10.2% |
49.5% |
32.3% |
32.3% |
-25.6% |
|
-14.1% |
|
|
P/E |
? |
|
-53.3 |
8.39 |
8.46 |
8.46 |
-8.06 |
|
-12.3 |
|
P/FCF |
|
|
20.3 |
7.68 |
15.4 |
15.4 |
-9.93 |
|
-6.91 |
|
P/S |
? |
|
145.1 |
5.77 |
3.67 |
3.67 |
5.55 |
|
5.38 |
|
P/BV |
? |
|
15.6 |
7.24 |
3.70 |
3.70 |
2.76 |
|
2.31 |
|
EV/EBITDA |
? |
|
-48.1 |
6.77 |
6.24 |
6.23 |
-9.33 |
|
-12.2 |
|
Debt/EBITDA |
|
|
6.30 |
-0.79 |
-0.90 |
-1.01 |
2.24 |
|
0.15 |
|
|
R&D/CAPEX, % |
|
|
2 032% |
701.1% |
823.8% |
823.8% |
685.3% |
|
634.2% |
|
|
CAPEX/Revenue, % |
|
|
24.6% |
1.60% |
2.08% |
2.08% |
10.3% |
|
14.7% |
|
| Moderna shareholders |
